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Medication errors can be frequent in hospitals; these errors are multidisciplinary and occur at various 
stages of the drug therapy. The present study evaluated the seriousness, the type and the drugs involved in 
medication errors reported at the Hospital de Clínicas de Porto Alegre. We analyzed written error reports 
for 2010-2011. The sample consisted of 165 reports. The errors identified were classified according to 
seriousness, type and pharmacological class. 114 reports were categorized as actual errors (medication 
errors) and 51 reports were categorized as potential errors. There were more medication error reports in 
2011 compared to 2010, but there was no significant change in the seriousness of the reports. The most 
common type of error was prescribing error (48.25%). Errors that occurred during the process of drug 
therapy sometimes generated additional medication errors. In 114 reports of medication errors identified, 
122 drugs were cited. The reflection on medication errors, the possibility of harm resulting from these 
errors, and the methods for error identification and evaluation should include a broad perspective of the 
aspects involved in the occurrence of errors. Patient safety depends on the process of communication 
involving errors, on the proper recording of information, and on the monitoring itself.
Uniterms: Medication/errors. Drug therapy. Patients/safety.
Erros envolvendo medicamentos ocorrem frequentemente em hospitais, possuem natureza multidisciplinar 
e podem ocorrer nas várias etapas da terapia medicamentosa. O estudo avaliou a seriedade, o tipo e os 
medicamentos envolvidos nos erros de medicação notificados no Hospital de Clínicas de Porto Alegre. 
Foram analisadas notificações de erros realizadas por escrito em 2010-2011. A amostra foi composta por 
165 notificações. Cento e catorze notificações foram classificadas como erros de fato (erros de medicação) 
e 51 notificações, como erros potenciais. Apesar de se ter realizado maior número de notificações de 
erros de medicação em 2011, comparativamente a 2010, não houve alteração significativa no perfil de 
seriedade destes eventos. O tipo de erro mais frequente foi o de prescrição (48,25%). Os erros ocorridos 
ao longo do processo geraram, em algumas situações, novos erros de medicação associados. Nas 114 
notificações de erros de medicação identificadas citaram-se 122 medicamentos. A reflexão sobre os erros 
de medicação e a possibilidade de danos decorrentes dos mesmos, assim como dos métodos para a sua 
identificação e avaliação, deve incluir uma ampla perspectiva dos aspectos envolvidos na sua ocorrência. 
A segurança dos pacientes depende deste processo de comunicação, do registro adequado das informações 
e do monitoramento propriamente dito.
Unitermos: Medicação/erros. Terapia medicamentosa. Pacientes/segurança.
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INTRODUCTION
The healthcare system is extremely complex. It 
involves critical situations of risk, an interaction between 
multiple professionals and institutions, and depends on 
significant support from technology. The characteristics 
of the system may heighten the risk of mistakes and 
worsen the consequences of these mistakes. In this sense, 
it is important to assess risk and damage to patients in the 
search for ultimate patient safety (Rosa, Perini, 2003). 
The World Health Organization definition of patient 
safety establishes that unnecessary harm or potential 
harm associated with healthcare should be reduced to an 
acceptable minimum (WHO, 2009).
Medication errors may be defined as any preventable 
event that may cause or lead to inappropriate medication 
use or patient harm while the medication is in the control 
of the healthcare professional, patient, or consumer. The 
error may be related to professional practice, to healthcare 
products, to procedures, to communication problems 
(including prescribing, product labeling, packaging, 
and nomenclature), to compounding, to dispensing, to 
distribution, to administration, to education, to monitoring, 
and to the proper use of medications (NCCMERP, 2001a).
International studies have established that 
the medication error rate varies from 1.5 to 35.0% 
depending on several factors. These factors include type 
of classification, method of error identification, and 
the common denominator adopted (Otero et al., 2008). 
According to Wannmacher (2005), recognizing errors 
is the best way to improve the quality and safety of 
healthcare activities.
Usually, medication errors are detected only 
if there are clinical consequences manifested by the 
patient, such as the presence of symptoms sometime after 
the administration of the medication, thus alerting the 
healthcare professionals (Carvalho, Cassiani, 2002). The 
clinical consequences of the error may be confounded with 
adverse reactions to medication, but medication errors 
are different from adverse drug reactions. According to 
the World Health Organization (WHO, 1972), an adverse 
reaction is any harmful or undesirable effect presented 
after administration of medication at doses normally used 
for prophylaxis, diagnosis, or treatment of diseases. It is 
not possible to prevent adverse reactions, even though the 
possibility of an adverse reaction is known.
The possibility that predictable harm may occur 
results in the need for establishing adequate prevention 
measures. The Precautionary Principle established by 
Hans Jonas (1994) is based on the Ethics of Responsibility. 
Healthcare professionals are always responsible for any 
action they carry out, but this does not imply in guilt by 
association. In this sense, Bioethics may help develop 
an adequate understanding of the need to establish 
contingency measures for predictable risks.
The implementation of systems for the detection 
and prevention of medication errors must be one of 
the pharmacovigilance goals at healthcare institutions. 
Nunes and colleagues (2008) underscored the need for 
systematic and continuous evaluation to decrease the 
incidence of errors and contribute to the identification and 
report of new error possibilities, which, in turn may have 
been mistakenly categorized as adverse drug reactions. 
These systems may also contribute to the identification 
of occurrences that would normally be kept secret (Nunes 
et al., 2008).
Spontaneous reporting, chart review, review of 
medical prescriptions, and direct observation are the main 
methods for identification and evaluation of medication 
errors (Coimbra, 2006). Each method has its advantages 
and disadvantages; the methods adopted should be adapted 
to institutional goals and used as management tools for 
healthcare quality improvement (Bohomol, Ramos, 2007).
During the process of implementation of an 
institutional program of pharmacovigilance, the methods 
may be implemented progressively. Spontaneous reporting 
may be the method of choice for an initial stage; it allows 
for the participation of all sectors of the institution and 
for the implementation of a more autonomous culture of 
error checking and evaluation. Other more direct methods 
may be interpreted by healthcare professionals as external 
evaluation measures.
In Brazil, there has been increasing interest and 
discussions about medication errors. However, the 
studies that have been published have issues that need 
to be addressed; these issues involve conceptual clarity, 
geographical distribution, professional perspective, and the 
focus of ethical aspects involved. In relation to conceptual 
clarity, first, there were studies that reported adverse 
events, adverse drug reactions, and medication errors 
indistinctly (Rissato et al., 2008). In relation to geographical 
distribution, there is a predominance of studies carried 
out in southeastern Brazil, especially São Paulo (Optiz, 
2006). Almost all studies adopt the point of view of nursing 
professionals (Telles Filho, Praxedes, 2009). Also, few 
Brazilian studies have addressed either the ethical aspects 
involved in medication errors or the most adequate way to 
address these situations (Coli et al., 2010).
The aim of the present study was to evaluate the 
seriousness, the type, and the medications involved in 
medication errors reported at the Hospital de Clínicas de 
Porto Alegre in 2010 and 2011.
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METHOD
The study was carried out at Hospital de Clínicas 
de Porto Alegre (HCPA). The HCPA is a general teaching 
hospital with a hospital bed capacity of 795, which are 
divided in 18 conventional inpatient units, five intensive 
care units, and the adults and children emergency units.
We carried out a retrospective, cross-sectional study 
to evaluate the medication error reports, submitted in 
written form to the Group for Safe Use of Medications 
(GUS, in Portuguese) at the HCPA, from January 
2010 to December 2011. The Group is constituted 
by representatives from the Medications Committee, 
Pharmaceutical Service, and Nursing Group. This group 
analyzes the error reports submitted through the voluntary 
reporting system at the HCPA. We excluded reports 
that did not have enough information for their correct 
categorization, the reports that were duplicated, and the 
reports that were made after the period investigated (even 
though they refer to an event that happened during the 
period). The study sample included 165 spontaneous error 
reports.
We carried out a survey of the GUS files with the aim 
of identifying in reports actual errors (medication errors) 
and potential errors (circumstances or events that may lead 
to errors). The medication errors identified were classified 
according to seriousness, type, and pharmacological class.
Seriousness was categorized using nine different 
categories, from A to I. The classification includes 
occurrence of an error; if the error reached the patient, or 
not; the harm associated with the error; and the necessary 
measures (Figure 1). The classification was based on 
the National Coordinating Council for Medication 
Error Reporting and Prevention Error Category Index 
(NCCMERP, 2001b).
The reports categorized as errors that actually 
occurred (category B-I) were also categorized as for the 
type of error according to the American Society of Health-
System Pharmacists (ASHP). The ASHP classifies errors 
as prescribing error, dispensing error, omission error, 
wrong time error, unauthorized drug error, improper dose 
error, wrong dosage-form error, wrong drug-preparation 
error, wrong administration-technique error, deteriorated 
drug error, monitoring error, compliance error, and other 
medication error (ASHP, 1993).
We carried out the pharmacological classification 
of drugs involved in errors. We used the Anatomical 
Therapeutic Chemical Classification System of the WHO 
Collaborating Centre for Drug Statistics Methodology. 
The drugs can be classified into five different levels 
according to: anatomical main group (first level), 
therapeutic main group (second level), therapeutic/
pharmacological subgroup (third level), chemical/
therapeutic/pharmacological subgroup (fourth level), and 
the chemical substance (fifth level) (WHO, 2012).
Statistical analyses were carried out to verify the 
frequency and association distributions between the 
variables. We used the chi-square test to evaluate the 
associations (using EPI INFO software, version 3.5.2). 
The level of significance was set at 5% (P=0.05).
In order to evaluate mistakes in the process of 
reporting medication errors, we also evaluated the reports 
of adverse drug reactions submitted to the Pharmaceutical 
Service at the HCPA in 2011.
The study was approved by the Ethics Committee 
of the HCPA (project number 10-0445). The researchers 
Error category Error occurrence Reached patient
Associated 
harm Necessary measures
A Potential No No No
B Yes No No No
C Yes Yes No No
D Yes Yes No Monitoring
E Yes Yes Temporary Medical intervention
F Yes Yes Temporary Hospitalization or prolonging hospital stay
G Yes Yes Permanent Variable
H Yes Yes Risk of death Vital support intervention
I Yes Yes Death -
FIGURE 1 - Classification of seriousness of medication errors according to the National Coordinating Council for Medication Error 
Reporting and Prevention (NCCMERP).
G. R. S. Dalmolin, E. T. Rotta, J. R. Goldim796
filled out and signed a form indicating the Terms of Use 
for the Data, which aimed to preserve the privacy of the 
information contained in the reports.
RESULTS AND DISCUSSION
The sample included 165 error reports with similar 
number of occurrences for each year: 84 in 2010 and 81 
in 2011. The reports were spontaneous and submitted by 
healthcare professionals from conventional inpatient units, 
intensive care units, and emergency units.
The seriousness of the reports showed that 114 
reports were actual errors (medication errors) and 51 
reports were categorized as potential errors. For 2010, 
34 of the 84 reports (40.48%) were evaluated as potential 
errors (category A). In 2011, 17 of the 81 reports (20.99%) 
were classified as category A. There was a significant 
association between the year of report and category A 
reports (X2=7.33; P=0.007) (Table I).
A possible explanation for the decrease in potential 
error situations may be the educational efforts of the 
GUS. The aim of these efforts was to better inform HCPA 
professionals about medication error situations; they 
included events and direct efforts of improvement of the 
potential error situations reported.
The reports of circumstances or events potentially 
associated with errors are of great importance for the 
implementation of prevention measures. The Precautionary 
Principle (Jonas, 1994) states that the existence of risk 
of serious harm, or of irreversible harm requires the 
implementation of measures to predict the occurrence of 
the damage. The implementation of educational measures 
is a current and necessary proposition for hospitals. These 
measures are a way of safeguarding the legitimate interests 
of those (that is, every admitted patient and of the society 
as a whole) who may need hospital services. Healthcare 
professionals face a great challenge of recognizing the 
possibility of harm and the need to evaluate harm based 
on the knowledge available (Goldim, 2002).
Evaluation of the second criterion of seriousness 
showed that 109 (66.06%) of the reports did not reach the 
patients (categories A and B), out of which 59 happened 
in 2010 and 50 in 2010. Comparison of the years 2010 and 
2011 did not show a significant association between not 
reaching (categories A and B) and reaching (categories C 
to I) the patient (X2=1.33; P>0.05) (Table 1). 
In 2010, the most frequent category was A (40.48%); 
but in 2011, the most frequent category was B (40.74%). 
The follow-up of reports during the two years showed 
that category B errors were the most frequently reported. 
In 2011, there was a 5.21% increase in the error reports 
that reached the patient but did not cause harm. This result 
suggests that professionals already adopted the practice of 
reporting error situations, but may still have difficulties 
informing situations in which errors reached the patient. 
This difficulty may be caused by several reasons that have 
been reported in previous studies; the reasons include 
shame, guilt, and fear (Santos et al., 2007).
According to NCCMERP taxonomy (NCCMERP, 
2001b), harm is defined as temporary or permanent 
impairment of the physical, emotional, or psychological 
function or structure of the body and/or pain resulting 
therefrom requiring intervention. All reports associated 
with harm resulted in temporary harm only (categories E 
and F). There were no reports involving permanent harm 
or fatal outcomes (categories G, H, and I) (Table I).
The results did not show a statistically significant 
association in relation to harm (X2=0.06; P>0.05). This 
result was obtained by the comparison of the categories 
that are not associated with harm (categories B, C, and 
D) with the categories that are associated with harm 
(categories E to I).
There was no significant association between the 
need to implement a measure (categories E to I) or at most 
monitor the patient (categories B to D) (X2=0.06; P>0.05). 
The necessary measures included medical intervention 
(category E), which occurred in 7.88% of reports, and 
prolonging hospital stay (category F), in 1.21% of cases.
In relation to seriousness, though there was an 
increase in medication error reports in 2011 in comparison 
to 2010, there was no significant change in the profile of 
seriousness of these events. The results indicate, however, 
that educational measures that address medication errors 
are fostering the reports of more serious situations.
The NCCMERP Medication Error Index was 
proposed in 1996 and revised in 2001. Several authors 
advocate it is the most adequate method (Santell et 
al., 2003; Forrey et al., 2007). However, more data 
from different institutions need to be collected (in 
methodologically similar fashion) so that comparisons 
can be made with the data presently available (Lacasa 
et al., 2012; Menendez et al., 2012). We identified two 
Brazilian studies that applied this classification. One 
investigated prescription errors (Néri et al., 2011), and the 
other investigated errors in the preparation of intravenous 
medications (Camerini, Silva, 2011). However, the two 
studies do not provide the same comprehensive approach 
of the present study.
From a Bioethics standpoint, the classification of 
seriousness raises some issues. If harm was inflicted upon 
a patient due to medication error, there may be doubts 
among the healthcare team about the communication to the 
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patients or their relatives. The ethical issue is not whether 
to communicate or not, but rather how to communicate to 
the patient and relatives, and when. The patient medical 
records, which belong to the patient, report this type of 
situation. In this sense, the adequate report of an error 
helps to build a relationship of trust between patient and 
healthcare staff.
After exclusion of the situations classified as potential 
error (category A), we carried out the classification of type 
of medication error (categories B to I) according to the 
ASHP taxonomy. The type of medication errors may be 
classified from prescription errors to compliance to the 
treatment itself (Table II).
The most frequent type of medication error 
associated with the process was prescribing error: 48.25% 
of cases during the two years of the study. Most cases of 
prescribing error did not reach the patient because they 
were intercepted by the nursing staff. Prescribing errors 
involved ambiguous information, duplicate medications, 
and mistakes associated incorrect information in the 
computer system. Ambiguous information is identified 
when the prescription defines that the medication 
should be used “as necessary” or “according to medical 
orientation.” Duplicate medications are identified when 
the same medication is included twice in the same 
prescription (at times with different dosages). Mistakes 
involving incorrect information are usually associated with 
units of measure, such as indicating milliliters instead of 
milligrams.
Elec t ron ic  p resc r ip t ion  of  medica t ion  i s 
internationally accepted as a tool that ensures safer use 
of medications; it reduces the medication error rates 
by facilitating the reading of the prescription (it avoids 
problems with understanding handwriting). However, if 
not used properly, electronic prescriptions may not help 
to ensure safer prescription of medications. The electronic 
prescription alone does not eliminate the possibility of 
medication errors (Koppel et al., 2005). The system 
adopted for electronic prescriptions should be constantly 
reevaluated. 
Dispensing errors were reported only in 2010. A 
previous study developed in the HCPA (Almeida, 2010) 
indicated that the bar code reading system associated 
with changes in the infrastructure and work processes are 
the major factors behind the reduction in error rates for 
dispensing drugs in the hospital.
The frequency of spontaneous reports of errors of 
omission (2.63%) and of wrong time error (1.75%) was 
low. This suggests these cases may be underreported in 
the spontaneous reports. In studies that carried out direct 
observation of the medication administration stage, the 
errors of omission and of wrong time were above 10.0% 
and 8.0%, respectively (Costa et al., 2006). These results 
corroborate Bohomol and Ramos (2007), who showed 
that professionals involved with the administration of 
medications do not consider omissions (which do reach 
the patient) an error. Similarly, these professionals 
characterize the wrong time in medication administration 
as a justifiable error due to the high number of patients 
attended or by the lack of sufficient medications. 
The administration of non-authorized medications 
was reported in 13 events (11.40%). In some of these 
situations the medication prescribed was administered 
to the wrong patient. This suggests that the first goal for 
patient safety (JCI, 2006), that is, the correct identification 
of patients, was not adequately met in these cases.
TABLE I - Seriousness classification for medication errors according to the National Coordinating Council for Medication Error 
Reporting and Prevention (NCCMERP), HCPA, 2010 - 2011 (N=165)
Error category N (2010) Fr (%) N (2011) Fr (%) Total (2010-1) Fr (%)
A 34 40.48 17 20.99 51 30.91
B 25 29.76 33 40.74 58 35.15
C 6 7.14 10 12.35 16 9.7
D 12 14.29 13 16.05 25 15.15
E 7 8.33 6 7.41 13 7.88
F 0 0 2 2.47 2 1.21
G 0 0 0 0 0 0
H 0 0 0 0 0 0
I 0 0 0 0 0 0
TOTAL 84 100 81 100 165 100
Notes: N= number of error reports Fr= percentage of error reports /total of error reports
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Improper dose errors (11.40%) were related to 
administration of drugs in doses higher or lower than 
prescribed, administration of an extra dose of the drug, and 
duplicate administration of a dose of the drug. They were 
mainly caused by poor understanding of prescriptions 
and failure of nursing staff to control the time of drug 
administration. In another Brazilian study (Teixeira, 
Cassiani, 2010), dose errors in drug administration were 
also among the three most common types of medication 
errors, accounting for 24.3% of medication errors related 
to drug doses administered differently than prescribed.
Thirteen events (11.40%) were assessed as wrong 
drug-preparation errors and eight events (7.02%) as wrong 
administration-technique errors. Miasso et al. (2006) 
analyzed the medication preparation and administration 
process in medical units at four Brazilian hospitals. Among 
the problems identified as contributing to the occurrence 
of medication errors, wrong drug-preparation errors and 
wrong administration-technique errors were observed in 
all hospitals.
Medication errors may generate additional 
associated errors, which occur exactly because there are 
successive actions, or actions that are associated with a 
chain of events. For example, there were prescribing errors 
and preparation errors that led to other errors associated 
with drug administration (omission error, improper dose 
error, wrong time error, and unauthorized drug error) in 
nine cases (7.89%), out of which five (10.0%) occurred in 
2010 and four (6.25%) in 2011.
The classification of type of medication error helps 
to identify which stages of the process of administering 
medications should be improved. In this sense, better 
communication between the professionals is a factor that 
deserves more attention. A culture of infallibility, which 
is present in the healthcare field, may lead to a lack of 
communication about mistakes between professionals. 
Spontaneous reporting may be inversely associated with 
the seriousness and the type of error that occur. Though it 
is a difficult task, it is necessary to separate errors caused 
by human error from errors caused by the system. The aim 
is not to find a culprit, but rather to establish personal and 
institutional accountability.
More than one medication may be included in 
the same error report. In the 114 reports there were 122 
drugs cited, which were classified according to the ATC 
classification system (Table III) using only the first level 
of the classification, which groups drugs according to 
anatomical main group.
Drugs in code N (nervous system) were the most 
frequent medications associated with reports (30.33%). For 
example, morphine and the antiepileptics carbamazepine 
and clonazepam are among the medications reported in 
the two years of study. 
Code B drugs (blood and blood-forming organs) and 
code J drugs (anti-infectives for systemic use) were next in 
the reports; 15.57% and 14.75% frequency in the reports.
In 2011 there was a 12.31% increase in reports of 
category J medications. The reports included, for example, 
TABLE II - Types of medication errors according to the American Society of Health-System Pharmacists (ASHP), HCPA, 2010 - 
2011 (N=114)
Type of error N (2010) Fr (%) N (2011) Fr (%) Total (2010-1) Fr (%)
Prescribing 24 48 31 48.44 55 48.25
Dispensing 5 10 0 0 5 4.39
Omission 2 4 1 1.56 3 2.63
Wrong time 2 4 0 0 2 1.75
Unauthorized drug 5 10 8 12.5 13 11.40
Improper dose 5 10 8 12.5 13 11.40
Wrong dosage-form 0 0 0 0 0 0
Wrong drug-preparation 4 8 9 14.06 13 11.40
Wrong administration-technique 3 6 5 7.81 8 7.02
Deteriorated drug 0 0 0 0 0 0
Monitoring 0 0 0 0 0 0
Compliance 0 0 0 0 0 0
Other 0 0 2 3.13 2 1.75
TOTAL 50 100 64 100 114 100
Notes: N=number of medication error reports Fr=percentage of medication error reports/total of medication error reports
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the following antibacterial drugs in more than one 
occasion: metronidazole, meropenem, and clarithromycin.
A study carried out in the state of Goiás, Brazil 
(Silva et al., 2011) evaluated 230 reports from the 
nursing staff and that contained medication errors. The 
main drugs associated with errors were antineoplastic 
and immunomodulating agents (code L; 24.3%), anti-
infectives for systemic use (code J; 20.9%), and blood and 
blood-forming organs (code B; 15.3%).
High-alert medications such as NPH insulin (code 
A), regular insulin (code A), and enoxaparine (code 
B) were associated with several error reports. These 
medications have an inherent risk for harming patients if 
there is a mistake in the process of drug administration. 
The seriousness of the errors associated with these drugs 
is high; the drugs may lead to permanent or fatal outcomes 
(Rosa et al., 2009). The present study suggests that there 
is still room at the HCPA for improvement in the third 
international goal for patient safety, that is, improvement 
of high-alert medications safety. A previous study by 
Franciscatto et al. (2011) had already reported the need to 
implement actions for improving this specific goal.
Once more, considering the classification of the 
medications involved in errors, patient medical records 
is an important document for evaluation and recording of 
information about prescription of medications and nursing 
reports of administration of the medication. Information 
about medication errors and about the medications 
themselves may be lost if not properly recorded. All 
healthcare professionals should be well-informed about 
the importance of recording possible errors and the drugs 
involved. The type of information necessary and the proper 
section for the description should be well-established. The 
report and recording of medication errors, including the 
description of the involved drug, ensure the monitoring of 
appropriate medication use.
In order to evaluate mistakes in the process of 
reporting medication errors, we also evaluated the reports 
of adverse drug reactions at the Pharmaceutical Service of 
the HCPA. There were only data for 2011. There were 12 
TABLE III - Drugs involved in medication error reports according to the Anatomical Therapeutic Chemical Classification System, 
HCPA, 2010 - 2011 (N=122)
ATC level 1 N (2010) Fr (%) N (2011) Fr (%) Total (2010-1) Fr (%)
A – Alimentary tract and metabolism 7 13.46 7 10 14 11.48
B – Blood and blood-forming organs 9 17.31 10 14.29 19 15.57
C – Cardiovascular system 5 9.62 4 5.71 9 7.38
D – Dermatologicals 0 0 0 0 0 0
G – Genitourinary system and sex 
hormones
1 1.92 0 0 1 0.82
H – Systemic hormonal preparations, 
excluding sex hormones and insulins
0 0 3 4.29 3 2.46
J – Anti-infectives for systemic use 4 7.69 14 20 18 14.75
L – Antineoplastic and 
immunomodulating agents
3 5.77 2 2.86 5 4.09
M – Musculoskeletal system 1 1.92 2 2.86 3 2.46
N – Nervous system 18 34.62 19 27.14 37 30.33
P – Antiparasitic products, insecticides 
and repellents
0 0 0 0 0 0
R – Respiratory system 2 3.85 4 5.71 6 4.92
S – Sensory organs 0 0 0 0 0 0
V – Various 0 0 0 0 0 0
Insufficient information for ATC 
classification
2 3.85 5 7.14 7 5.74
TOTAL 52a 100 70b 100 122 100
Notes: N= number of drugs cited in medication error reports Fr=percentage of drugs cited in medication error reports /total of 
drugs cited in medication error reports
a In 2 reports more than one medication was cited. b In 6 reports more than one medication was cited.
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medication errors in 334 reports of adverse drug reactions. 
Eleven of these errors were code E, and one was code F. 
The types of error reported included prescribing errors, 
wrong drug-preparation error, and wrong administration-
technique error. The drugs involved in adverse reaction 
reports included amphotericin b, with more than one 
occurrence, and vancomycin. The rate of adverse drug 
reactions mistakenly reported as medication errors 
was 3.59%; all had associated harm. The occurrence of 
associated harm may have been a confounding factor in the 
reporting of medication errors as an adverse drug reaction.
Spontaneous reports of errors or potential error 
situations may help identify failures and weaknesses in 
the medication system in an Institution. If the spontaneous 
report system is well-structured and adequately managed, it 
may gradually ensure the participation of all collaborators 
in an Institution. As the data obtained from reports are 
converted into information through categorization and 
evaluation, a process of decision-making begins to take 
place. This process allows for actions to be carried out 
in the sense of correcting, whenever possible, these 
situations.
This study had some limitations regarding the 
quality of error reports. The voluntary reporting system 
at the HCPA was made available to staff at the end of 
2009. Medication errors can be reported spontaneously 
through free text or standardized form. In most reports 
received during the study period the events were 
described by free text.Some reports did not have enough 
information for their correct categorization. Thus, the GUS 
meeting minutes were also used to search for additional 
information. Nevertheless, some reports (9) could not be 
used in the study.
CONCLUSION
Based on the results for the medication error reports 
in 2010 and 2011 at the HCPA:
A)  In relation to seriousness, 30.91% of reports were 
about potential error (category A). In 60.0% of 
reports, medication errors did not reach the patient 
(category B) or reached the patient but did not cause 
harm (C and D). In the remaining reports, there was 
temporary harm associated (E and F); there were no 
reports associated with permanent harm or death (G, 
H, and I).
B)  In relation to type of error, 48.25% of reports were 
associated with prescription. There were prescribing 
errors and preparation errors that led to other errors 
associated with drug administration in nine cases 
(7.89%).
C)  In relation to the drugs involved, including high-alert 
medications, there was a predominance (60.65%) 
of medications for the nervous system (code N), 
blood and blood-forming organs (code B), and anti-
-infectives for systemic use (code J).
The reflection on medication errors and the possible 
harm that may ensue should follow a broad investigation of 
aspects involved in the occurrence of the error. The safety 
of patients depends on the process of communication of 
errors, on the adequate report and recording of information, 
and on the monitoring itself. All of these steps depend on 
the adequate understanding of the importance of each 
step, and on the compliance, on the part of all healthcare 
professionals.
The authors suggest that further research be 
conducted in order to study how the discussion of 
medication errors is flowing among professionals that act 
on the different stages of the medication system, seeking 
to verify the barriers and incentives that may prevent or 
encourage the reporting of medication errors.
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